AstraZeneca shares tumbled nearly 10% in London after a late-stage trial for an experimental heart disease failed to meet its ...
Moderna said on Thursday it has secured a European Commission contract to supply its respiratory syncytial virus vaccine to ...
Health Minister Dr Aaron Motsoaledi reveals the ongoing challenges of medicine stock disruptions in South Africa, detailing ...
(Nasdaq: IONS) and partner AstraZeneca today announced that the CARDIO-TTRansform Phase 3 trial for eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) did not meet ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Andy Smith is a Certified Financial Planner (CFP®), licensed realtor and educator with over 35 years of diverse ...
The CARDIO-TTRansform Phase III trial 1 for AstraZeneca and Ionis' Wainua (eplontersen) in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) did not meet the primary efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results